Glutamic Acid

Glutamic Acid

SCHEMBL17477271

CC(=O)O.CC(=O)O.CC(=O)O.CC(=O)O.CC(=O)O.CC(=O)O.NCCN.N[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Glutamic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 2/20 0.75
GRM8 O00222 2/20 0.75
GRM6 O15303 2/20 0.75
GRM7 Q14831 2/20 0.75
GRM4 Q14833 2/20 0.75
CYP1A2 P05177 2/20 0.75
GRIN2D O15399 1/20 0.75
GRIN3B O60391 1/20 0.75
GRIK1 P39086 1/20 0.75
GRM5 P41594 1/20 0.75
GRIA1 P42261 1/20 0.75
GRIA2 P42262 1/20 0.75
GRIA3 P42263 1/20 0.75
SLC1A3 P43003 1/20 0.75
SLC1A2 P43004 1/20 0.75
SLC1A1 P43005 1/20 0.75
GRIA4 P48058 1/20 0.75
GRIN1 Q05586 1/20 0.75
GRIN2A Q12879 1/20 0.75
GRIK2 Q13002 1/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
D-Glutamate SCHEMBL28509459 0.94 GRM8 (0.86) GSRGRM8GRM6GRM7GRM4
Glutamic Acid SCHEMBL8032708 0.94 GSR (0.86) GSRGRM8GRM6GRM7GRM4
Glutamic Acid SCHEMBL2803034 0.94 GRM8 (0.86) GSRGRM8GRM6GRM7GRM4
D-Glutamate SCHEMBL184512 0.94 GRM8 (0.86) GSRGRM8GRM6GRM7GRM4
Glutamic Acid SCHEMBL7616974 0.94 GSR (0.86) GSRGRM8GRM6GRM7GRM4
D-Glutamate SCHEMBL15797537 0.94 GRM8 (0.86) GSRGRM8GRM6GRM7GRM4
D-Glutamate SCHEMBL8391023 0.94 GSR (0.86) GSRGRM8GRM6GRM7GRM4
Glutamic Acid SCHEMBL184513 0.94 GRM8 (0.86) GSRGRM8GRM6GRM7GRM4
D-Glutamate SCHEMBL8560542 0.94 GSR (0.86) GSRGRM8GRM6GRM7GRM4
D-Glutamate SCHEMBL27884184 0.94 GRM8 (0.86) GSRGRM8GRM6GRM7GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10479925-B2 Use of hexamethylenetetramine intensifier for high temperature emulsified acid system HALLIBURTON ENERGY SERVICES, INC. (US) 2019-11-19 US disclosed
US-10301522-B2 Sulfide stress cracking inhibitors HALLIBURTON ENERGY SERVICES, INC. (US) 2019-05-28 US disclosed
US-20170247601-A1 METHOD FOR INHIBITING SULFIDE STRESS CRACKING OF METALS HALLIBURTON ENERGY SERVICES, INC. (US) 2017-08-31 US disclosed
US-20170233638-A1 Use of Hexamethylenetetramine Intensifier for High Temperature Emulsified Acid System HALLIBURTON ENERGY SERVICES, INC. (US) 2017-08-17 US disclosed
US-20170121584-A1 Sulfide Stress Cracking Inhibitors HALLIBURTON ENERGY SERVICES, INC. (US) 2017-05-04 US disclosed
US-9587157-B2 Sulfide stress cracking inhibitors HALLIBURTON ENERGY SERVICES, INC. (US) 2017-03-07 US disclosed
US-20160272867-A1 SULFIDE STRESS CRACKING INHIBITORS HALLIBURTON ENERGY SERVICES, INC. 2016-09-22 US disclosed
WO-2016060671-A1 METHOD FOR INHIBITING SULFIDE STRESS CRACKING OF METALS HALLIBURTON ENERGY SERVICES, INC. (US) 2016-04-21 WO disclosed
WO-2016043703-A1 USE OF HEXAMETHYLENETETRAMINE INTENSIFIER FOR HIGH TEMPERATURE EMULSIFIED ACID SYSTEM HALLIBURTON ENERGY SERVICES, INC. (US) 2016-03-24 WO disclosed
WO-2016018311-A1 SULFIDE STRESS CRACKING INHIBITORS HALLIBURTON ENERGY SERVICES, INC. (US) 2016-02-04 WO disclosed